Molecular characterization of the p53 and RB1 tumor suppressor pathways in human prostate carcinomas

Keyphrases

• Cyclin-dependent Kinase Inhibitor 100%
• Molecular Characterization 100%
• Cyclin-dependent Kinase Inhibitor 2A (CDKN2A) 100%
• Human Prostate 100%
• Prostate Carcinoma 100%
• Tumor Suppressor Activity 100%
• P53 Pathway 66%
• PCR Analysis 33%
• Tumor Suppressor Gene 33%
• Apoptosis 33%
• Tumor Suppressor 33%
• Tumor 33%
• Quantitative PCR 33%
• Cell Cycling 33%
• DNA Sequencing 33%
• Phosphorylation 33%
• Cell Cycle Arrest 33%
• DNA Damage 33%
• Human Cancer 33%
• Negative Regulation 33%
• P53 Expression 33%
• Altered Expression 33%
• Patient Characteristics 33%
• Molecular Abnormalities 33%
• Wild-type p53 33%
• Molecular Circuits 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Protein P53 100%
• Prostate Carcinoma 100%
• Tumor Suppressor Protein 100%
• Cyclin Dependent Kinase Inhibitor 50%
• Neoplasm 16%
• Malignant Neoplasm 16%